Barili, Valeria
Fisicaro, Paola
Montanini, Barbara http://orcid.org/0000-0002-5419-7975
Acerbi, Greta
Filippi, Anita
Forleo, Giovanna
Romualdi, Chiara
Ferracin, Manuela http://orcid.org/0000-0002-1595-6887
Guerrieri, Francesca http://orcid.org/0000-0002-2021-4394
Pedrazzi, Giuseppe http://orcid.org/0000-0002-5971-2040
Boni, Carolina
Rossi, Marzia
Vecchi, Andrea
Penna, Amalia
Zecca, Alessandra
Mori, Cristina
Orlandini, Alessandra
Negri, Elisa
Pesci, Marco
Massari, Marco http://orcid.org/0000-0003-4234-1973
Missale, Gabriele
Levrero, Massimo
Ottonello, Simone
Ferrari, Carlo
Funding for this research was provided by:
Regione Emilia-Romagna (PRUa1RI-2012-006)
Article History
Received: 25 July 2018
Accepted: 11 December 2019
First Online: 30 January 2020
Competing interests
: M.L.: Consultant for Gilead, Jansen, BMS, Arbutus, Galapagos, Assembly Pharma, Sanofi/Aventis. C.F.: Consultant for Gilead Srl, Abbvie, Arrowhead, Humabs, Abivax, MSD; grants from Gilead Srl, Bristol Squibb, Roche Spa, Abbvie, Janssen Cilag.